Known Alzheimer's disease genes account for only 30% of genetic activity of the disease. With 70% of the genetic component of Alzheimer's unknown, not even the best efforts can develop effective therapies to slow, stop or reverse the disease. Cure Alzheimer's Fund is going to the heart of this problem with the Alzheimer's Genome Project Intiative.
 
A+ | A- | Reset
Dr. William E. Trueheart Print

Dr. William E. Trueheart is President and Chief Executive Officer of The Pittsburgh Foundation.

Before joining The Pittsburgh Foundation, Dr. Trueheart served as President and Chief Executive Officer of Reading Is Fundamental, Inc., Prior to that, he was President of Bryant College in Rhode Island, the first African American to head a four-year private college in New England. He also served Bryant College as Executive Vice President and member of its Board of Trustees. He was Associate Secretary of Harvard University in its Office of Governing Boards and served as Assistant Dean and Director of the Master in Public Administration Program at the John F. Kennedy School of Government, and was a member of that School's Visiting Committee.

He currently serves on the Boards of Independent Sector (Board Chair), the University of Pittsburgh, the Allegheny Conference on Community Development, Pittsburgh Regional Healthcare Initiative, the Nellie Mae Education Foundation, and Highmark Blue Cross/Blue Shield. He also serves on the Visiting Committee of the JFK School of Government at Harvard University.

Dr. Trueheart earned his BA degree in political science and economics at the University of Connecticut, his MPA at the Harvard University John F. Kennedy School of Government, and EdD at the Graduate School of Education at Harvard University.

 
< Prev   Next >